Discordant vascular parameter measurements in diabetic and non-diabetic eyes detected by different optical coherence tomography angiography devices.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 10 02 2020
accepted: 30 05 2020
entrez: 17 6 2020
pubmed: 17 6 2020
medline: 29 8 2020
Statut: epublish

Résumé

To compare quantitative changes in macular parameters in diabetic patients detected by two optical coherence tomography angiography (OCTA) instruments. 80 phakic eyes were classified as no diabetes, diabetes without diabetic retinopathy (DR), mild non-proliferative diabetic retinopathy (NPDR), and severe NPDR or proliferative DR (PDR). OCTA was performed using devices from two manufacturers (Zeiss and Heidelberg). Superficial and deeper vascular skeleton density (SVSD, DVSD), superficial and deeper vessel area density (SVAD, DVAD), choriocapillaris flow voids (CCFV), and choroidal flow voids (CFV) were calculated. Inter-device comparisons were performed using the size comparison index (SCI) and the discrepancy index (DI). The two devices were inconsistent in SVSD, DVSD, DVAD, CCFV and CFV parameters (all P < 0.05). In addition, the SCI was positive for DVAD (all P < 0.001) and negative for SVSD, DVSD, CCFV and CFV in all groups (all P <0.001), except for DVSD in severe NPDR or PDR. The discrepancy index was not significantly different among groups for SVD, SPD, DVD, DPD and CFV (all P> 0.05). The mean DI of CCFV was statistically different between the four groups (P < 0.001). The two instruments were largely inconsistent in the measurement of macular parameters relevant to DR. The choice of imaging device can impact OCTA analytics and should be taken into account when drawing conclusions about DR-related changes.

Identifiants

pubmed: 32544179
doi: 10.1371/journal.pone.0234664
pii: PONE-D-20-03817
pmc: PMC7297376
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0234664

Subventions

Organisme : NEI NIH HHS
ID : R01 EY024004
Pays : United States

Déclaration de conflit d'intérêts

No authors have competing interests.

Références

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3065-3072
pubmed: 28622398
Ophthalmologica. 2018;239(2-3):61-73
pubmed: 29268269
J Diabetes Res. 2019 Jun 12;2019:2547216
pubmed: 31281849
Int J Biomed Imaging. 2012;2012:509783
pubmed: 22792084
Retina. 2015 Nov;35(11):2353-63
pubmed: 26465617
Sci Rep. 2017 Feb 10;7:42201
pubmed: 28186181
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):203-211
pubmed: 29340648
Graefes Arch Clin Exp Ophthalmol. 2016 Aug;254(8):1453-1461
pubmed: 27109344
JAMA Ophthalmol. 2017 Apr 1;135(4):306-312
pubmed: 28208170
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5893-5903
pubmed: 30550612
Biochem Med (Zagreb). 2015 Jun 05;25(2):141-51
pubmed: 26110027
Am J Ophthalmol. 2016 Oct;170:58-67
pubmed: 27496785
J Biomed Opt. 2015 Oct;20(10):100901
pubmed: 26473588
Prog Retin Eye Res. 2016 Mar;51:156-86
pubmed: 26297071
Invest Ophthalmol Vis Sci. 2011 Dec 09;52(13):9379-90
pubmed: 22016060
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO307-BIO315
pubmed: 29059262
Ophthalmology. 1991 May;98(5 Suppl):807-22
pubmed: 2062514
PLoS One. 2017 May 10;12(5):e0177059
pubmed: 28489918
J Biomed Opt. 2016 Jun 1;21(6):66008
pubmed: 27286188
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT362-70
pubmed: 27409494
Ophthalmologica. 2017;237(4):238-246
pubmed: 28433988
Am J Ophthalmol. 2015 Jul;160(1):35-44.e1
pubmed: 25896459
Br J Ophthalmol. 2019 Apr;103(4):452-456
pubmed: 29793926
Ophthalmologica. 2018;239(2-3):74-84
pubmed: 29353272
J Vitreoretin Dis. 2018 May-Jun;2(3):146-154
pubmed: 29930992
PLoS One. 2018 Oct 18;13(10):e0206045
pubmed: 30335839
Am J Ophthalmol. 2018 Feb;186:25-31
pubmed: 29169882
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3178-83
pubmed: 17591887
Graefes Arch Clin Exp Ophthalmol. 1994 Jun;232(6):361-7
pubmed: 8082844
Retina. 2015 Nov;35(11):2161-2
pubmed: 26502006
JAMA Ophthalmol. 2017 Apr 1;135(4):370-376
pubmed: 28301651
Am J Ophthalmol. 2018 Oct;194:26-34
pubmed: 30053475

Auteurs

Yi Chen (Y)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.
Shenzhen Eye Hospital, Shenzhen Key Laboratory of Ophthalmology, Affiliated Shenzhen Eye Hospital of Jinan University, Shenzhen, China.

Sawarin Laotaweerungsawat (S)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.
Department of Ophthalmology, Charoenkrung Pracharak Hospital, Bangkok, Thailand.

Tong Zhao (T)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.
Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China.

Zeeshan Haq (Z)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.

Xiuyun Liu (X)

Department of Physiological Nursing, University of California, San Francisco, CA, United States of America.

Catherine Psaras (C)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.

Daphne Yang (D)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.

Jay M Stewart (JM)

Department of Ophthalmology, University of California, San Francisco, CA, United States of America.
Department of Ophthalmology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, CA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH